{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T03:14:32Z","timestamp":1775790872998,"version":"3.50.1"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T00:00:00Z","timestamp":1391558400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0088323","type":"journal-article","created":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T22:21:48Z","timestamp":1391638908000},"page":"e88323","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Targeting Human Papillomavirus to Reduce the Burden of Cervical, Vulvar and Vaginal Cancer and Pre-Invasive Neoplasia: Establishing the Baseline for Surveillance"],"prefix":"10.1371","volume":"9","author":[{"given":"Mari","family":"Nyg\u00e5rd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo Terning","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joakim","family":"Dillner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Munk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristj\u00e1n","family":"Oddsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laufey","family":"Tryggvadottir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Hortlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Li","family":"Liaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik J.","family":"Dasbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne Kr\u00fcger","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,2,5]]},"reference":[{"key":"ref1","unstructured":"IARC (2007) Human Papillomaviruses. Lyon: WHO Press. 978\u201392\u2013832\u20131290\u20134 978\u201392\u2013832\u20131290\u20134."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ejca.2009.07.019","article-title":"HPV infection in Europe","volume":"45","author":"H De Vuyst","year":"2009","journal-title":"Eur J Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"JS Smith","year":"2007","journal-title":"Int J Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/ijc.23712","article-title":"Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark","volume":"123","author":"SK Kjaer","year":"2008","journal-title":"Int J Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.critrevonc.2008.02.012","article-title":"Review of squamous premalignant vulvar lesions","volume":"68","author":"HP van de Nieuwenhof","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"H De Vuyst","year":"2009","journal-title":"Int J Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1158\/1055-9965.EPI-09-0067","article-title":"Human papillomavirus infections and vulvar disease development","volume":"18","author":"SM Garland","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ygyno.2010.02.001","article-title":"Defining detection threshold and improving analytical proficiency of HPV testing in clinical specimens","volume":"117","author":"FY Chao","year":"2010","journal-title":"Gynecol Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"S de Sanjose","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"S de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1055-9965.EPI-07-2922","article-title":"A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States","volume":"17","author":"RP Insinga","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/AOG.0b013e31819bd6e0","article-title":"Human Papillomavirus Type-Distribution in Vulvar and Vaginal Cancers and Their Associated Precursors","volume":"113","author":"JS Smith","year":"2009","journal-title":"Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60852-6","article-title":"Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials","volume":"369","author":"KA Ault","year":"2007","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(09)60691-7","article-title":"Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24\u201345 years: a randomised, double-blind trial","volume":"373","author":"N Munoz","year":"2009","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"J Paavonen","year":"2009","journal-title":"Lancet"},{"key":"ref16","first-page":"197","article-title":"Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18\u201326 years from the National HPV Vaccination Program Register","volume":"35","author":"J Brotherton","year":"2011","journal-title":"Commun Dis Intell"},{"key":"ref17","first-page":"S1","article-title":"Prediction of cancer incidence in the Nordic countries up to the year 2020","volume":"11","author":"B Moller","year":"2002","journal-title":"Eur J Cancer Prev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.ejca.2008.10.037","article-title":"Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness","volume":"45","author":"IK Larsen","year":"2009","journal-title":"Eur J Cancer"},{"key":"ref19","unstructured":"Tavassoli F, Devilee P, editors (2003) Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC<italic>Press<\/italic>."},{"key":"ref20","unstructured":"WHO (1992) The ICD-10 classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization. 362 p."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1403494810393563","article-title":"The Danish Pathology Register","volume":"39","author":"B Bjerregaard","year":"2011","journal-title":"Scand J Public Health"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2303.2010.00783.x","article-title":"Cervical cancer: cytological cervical screening in Iceland and implications of HPV vaccines","volume":"21","author":"K Sigurdsson","year":"2010","journal-title":"Cytopathology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/0284186X.2011.624545","article-title":"Quality assessment of the registration of vulvar and vaginal premalignant lesions at the Cancer Registry of Norway","volume":"51","author":"E Enerly","year":"2012","journal-title":"Acta Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/jnci\/djn099","article-title":"Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden","volume":"100","author":"B Andrae","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"ref25","unstructured":"dos Santos Silva I (1999) Cancer Epidemiology: Principles and Methods. Lyon: IARC."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"C de Martel","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/oxfordjournals.aje.a121617","article-title":"Proportion of disease caused or prevented by a given exposure, trait or intervention","volume":"99","author":"OS Miettinen","year":"1974","journal-title":"Am J Epidemiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/eurpub\/ckp023","article-title":"The relationship between age at drinking onset and subsequent binge drinking among women","volume":"19","author":"M Eliasen","year":"2009","journal-title":"Eur J Public Health"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/sti.2009.038273","article-title":"Association between smoking and genital warts: longitudinal analysis","volume":"86","author":"BT Hansen","year":"2010","journal-title":"Sex Transm Infect"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1600-0412.2010.01066.x","article-title":"Women\u2019s sexual behavior. Population-based study among 65,000 women from four Nordic countries before introduction of human papillomavirus vaccination","volume":"90","author":"KE Jensen","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/eurpub\/ckr055","article-title":"Young age at first intercourse and risk-taking behaviours\u2013a study of nearly 65 000 women in four Nordic countries","volume":"22","author":"TB Olesen","year":"2012","journal-title":"Eur J Public Health"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/522863","article-title":"The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries","volume":"196","author":"SK Kjaer","year":"2007","journal-title":"J Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000325957","article-title":"Pap smear screening in women under 30 in the Norwegian Coordinated Cervical Cancer Screening Program, with a comparison of immediate biopsy vs Pap smear triage of moderate dysplasia","volume":"50","author":"JF Nygard","year":"2006","journal-title":"Acta Cytol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/j.1600-0412.1999.780602.x","article-title":"The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995","volume":"78","author":"K Sigurdsson","year":"1999","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"MR McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"a1343","DOI":"10.1136\/bmj.a1343","article-title":"Pregnancy outcome in women before and after cervical conisation: population based cohort study","volume":"337","author":"S Albrechtsen","year":"2008","journal-title":"BMJ"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1080\/00016340701279145","article-title":"Loop electrosurgical excision of the cervix and the subsequent risk of preterm delivery","volume":"86","author":"B Nohr","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/jnci\/djs395","article-title":"Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis","volume":"104","author":"N Van de Velde","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/j.ejca.2009.07.023","article-title":"The current state of introduction of HPV vaccination into national immunisation schedules in Europe: results of the VENICE 2008 survey","volume":"45","author":"D Levy-Bruhl","year":"2009","journal-title":"Eur J Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"NW Bulkmans","year":"2007","journal-title":"Lancet"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"P Naucler","year":"2007","journal-title":"N Engl J Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"G Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","author":"SK Kjaer","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"D Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jcv.2012.02.022","article-title":"Brush-based self-sampling in combination with GP5+\/6+-PCR-based hrHPV testing: High concordance with physician-taken cervical scrapes for HPV genotyping and detection of high-grade CIN","volume":"54","author":"MG Dijkstra","year":"2012","journal-title":"J Clin Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/pubmed\/fds040","article-title":"Modeling the impact of screening policy and screening compliance on incidence and mortality of cervical cancer in the post-HPV vaccination era","volume":"34","author":"BF de Blasio","year":"2012","journal-title":"J Public Health (Oxf)"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ejca.2008.11.037","article-title":"Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age","volume":"45","author":"HP van de Nieuwenhof","year":"2009","journal-title":"Eur J Cancer"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00001703-200202000-00007","article-title":"Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasia","volume":"14","author":"EA Joura","year":"2002","journal-title":"Curr Opin Obstet Gynecol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa0810097","article-title":"Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia","volume":"361","author":"GG Kenter","year":"2009","journal-title":"N Engl J Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1071\/SHv10n6ab27","article-title":"27. Natural history of anal HPV in heterosexual women and risks associated with persistence","volume":"10","author":"AB Moscicki","year":"2013","journal-title":"Sex Health"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Ouhoummane N, Steben M, Coutlee F, Vuong T, Forest P, <etal>et al<\/etal>.. (2013) Squamous anal cancer: Patient characteristics and HPV type distribution. Cancer Epidemiol.","DOI":"10.1016\/j.canep.2013.09.015"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/503330a","article-title":"HPV: Sex, cancer and a virus","volume":"503","author":"M Scudellari","year":"2013","journal-title":"Nature"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaad.2012.12.973","article-title":"Two major pathways of penile carcinogenesis: HPV-induced penile cancers overexpress p16ink4a, HPV-negative cancers associated with dermatoses express p53, but lack p16ink4a overexpression","volume":"69","author":"S Mannweiler","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Chirila M, Bolboaca SD (2013) Clinical efficiency of quadrivalent HPV (types 6\/11\/16\/18) vaccine in patients with recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol.","DOI":"10.1007\/s00405-013-2755-y"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/sextrans-2011-050234","article-title":"The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme","volume":"87","author":"TR Read","year":"2011","journal-title":"Sex Transm Infect"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/OLQ.0b013e31827bd66b","article-title":"Significant decrease in the incidence of genital warts in young danish women after implementation of a national human papillomavirus vaccination program","volume":"40","author":"L Baandrup","year":"2013","journal-title":"Sex Transm Dis"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Leval A, Herweijer E, Ploner A, Eloranta S, Fridman Simard J, <etal>et al<\/etal>.. (2013) Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study. J Natl Cancer Inst.","DOI":"10.1093\/jnci\/djt032"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0088323","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T10:39:26Z","timestamp":1565174366000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0088323"}},"subtitle":[],"editor":[{"given":"Surinder K.","family":"Batra","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,5]]},"references-count":57,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0088323","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,5]]}}}